HCL
Funder
307 Projects, page 1 of 62
assignment_turned_in ProjectFrom 2023Partners:Institut National des Sciences Appliquées de Lyon - Laboratoire dIngénierie des Matériaux Polymères, HCLInstitut National des Sciences Appliquées de Lyon - Laboratoire dIngénierie des Matériaux Polymères,HCLFunder: French National Research Agency (ANR) Project Code: ANR-22-CE19-0030Funder Contribution: 401,602 EURIn recent decades, there has been a tremendous increase in the spatial resolution of array sensors, which can now exceed 100 megapixels at low cost, and which has revolutionized biomedical imaging. As spatial resolution has become less and less of an issue, the spectral imaging capabilities have remained as a blind spot. Current spectral imaging technologies lack sufficient spectral resolution, speed, robustness to noise, versatility, and cost effectiveness to change the present biomedical paradigm, which is based on few-color imaging. The main objective of this project is to reshape spectral imaging, by developing a computational framework for high spectral resolution imaging, where physics, computer science, and applied mathematics are put together, to make it possible to image 10 to 1,000 times faster than with current techniques, while also resolving weak signals that cannot be detected at the present time. Motivated by recent advances and deep learning, we propose to shape and manipulate light with spatial light modulators, to acquire multiple pixels at the same time, to provide improved signal-to-noise ratios, while our algorithms will be used to reconstruct high spectral resolution images in real time. In this project, we will bring this new framework for hyperspectral imaging to the surgical operating room. By providing hyperspectral information in real time during neurosurgery, we will limit the requirement to time-consuming biopsies and help the surgeon to perform safer and less invasive surgery, which will in turn improve survival rates for the patients.
more_vert assignment_turned_in ProjectFrom 2012Partners:ComUE Lyon Saint-Etienne, Fondation Mérieux, INSERM Délégation Auvergne-Rhône-Alpes, CNRS Rhône Auvergne (Villeurbanne), HCL +7 partnersComUE Lyon Saint-Etienne,Fondation Mérieux,INSERM Délégation Auvergne-Rhône-Alpes,CNRS Rhône Auvergne (Villeurbanne),HCL,INRA CLERMONT- FERRAND/THEIX,VetAgro Sup,Institut Mérieux (France),COMUE Université de Lyon,Institut Pasteur,Ecole Normale Supérieure de Lyon,Institut National des Sciences Appliquées de Lyon - Laboratoire dIngénierie des Matériaux PolymèresFunder: French National Research Agency (ANR) Project Code: ANR-11-LABX-0048Funder Contribution: 3,980,780 EURmore_vert assignment_turned_in ProjectFrom 2023Partners:SATT Pulsalys, SATT Conectus, IRD MARSEILLE, INSERM, UPEC +20 partnersSATT Pulsalys,SATT Conectus,IRD MARSEILLE,INSERM,UPEC,INRA Transfert (France),SATT AxLR,SATT Erganeo,HCL,AMU,SATT Ouest Valorisation,SATT SAYENS,Université Côte d'Azur,Institut National des Sciences Appliquées de Lyon - Laboratoire dIngénierie des Matériaux Polymères,Nantes Université,SATT TOULOUSE TECH TRANSFER,Université de Tours,SATT Sud-Est,Xlim UMR 7252 CNRS/ Université de Limoges,AP-HP,SATT Nord,Inserm Transfert,SATT Linksium,Institut Pasteur Lille,CNRS INNOVATIONFunder: French National Research Agency (ANR) Project Code: ANR-21-MATP-0701Funder Contribution: 7,000,000 EURmore_vert assignment_turned_in ProjectPartners:HUS, Groupe Hospitalier Pitié Salpétrière, HUG, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Poitiers +10 partnersHUS,Groupe Hospitalier Pitié Salpétrière,HUG,Hôpital Claude Huriez,Centre Hospitalier Universitaire de Poitiers,Centre Hospitalier Universitaire de Toulouse,Centre Hospitalier Universitaire de Limoges,Institut Paoli-Calmettes- (IPC),CHRU MTP,Hôpital Necker- Enfants malades,HCL,Institut de cancérologie Lucien Neuwirth,CHU Nantes - Hôtel Dieu,CHU,Groupe Hospitalier Henri Mondor - Albert ChenevierFunder: Institut National du Cancer Project Code: INCa-DGOS-11089more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2025 - 2029Partners:University of Bristol, SERGAS, AP-HP, INSERM, EUROPEAN PATIENTS FORUM +19 partnersUniversity of Bristol,SERGAS,AP-HP,INSERM,EUROPEAN PATIENTS FORUM,UCD,Lancaster University,ULB,University of Verona,UCG,nile,BIM,NWO-I,UCL,Oslo University Hospital,Collectif No Fakemed,CNRS,Inserm Transfert,ECRIN,INSERM,HCL,UAntwerpen,LES MARKABIENS,Medical University of ViennaFunder: European Commission Project Code: 101156304Funder Contribution: 17,042,200 EURRecent pandemics showed Europe how serious health threats can be to society. Proactive approaches are needed to ensure that medical countermeasures are available during pandemics. PROACT EU-Response’s overarching objective is to prepare Europe for future pandemics by strengthening upon existing networks of experts and civil society focused on clinical therapeutic platform trials within hospital inpatient settings across Europe. In case of an outbreak, this network will provide capacity to pivot rapidly to implement large, multi-country platform trials studying therapeutics and diagnostic-tool performance. Underpinned by strong community involvement and further strengthened by the inclusion of social and implementation scientists, PROACT EU-Response centres on six objectives: expand a solid network of clinical centres across Europe that will implement a clinical trial assessing a syndromic approach for respiratory viral infections; strengthen a laboratory network to identify pathogens and biomarkers of disease monitoring for routine surveillance; support a network of methodologists and trialists who will ensure the trials’ logistical and methodological aspects; initiate a network of professionals to work on preparedness tools to ensure a smooth pivot from inter-pandemic to the pandemic period in case of an outbreak; build a network of social science researchers who will provide nuanced understanding of the social contexts; and establish a community group to work on activities that will empower patients and citizens in Europe regarding their own health and educate them about science and health issues. By bringing together scientists, social science researchers, and civil society members, PROACT EU-Response will benefit the entire European population and beyond through decreased mortality and morbidity associated with emerging diseases, lower societal economic costs of morbidity, strengthened research and innovation expertise, human capacities, and know-how for combatting communicable diseases.
more_vert
chevron_left - 1
- 2
- 3
- 4
- 5
chevron_right
